Valuation (76%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.37 | N/A |
| PEG Ratio (TTM) | -0.37 | N/A |
| P/S Ratio (TTM) | 0.21 | N/A |
| P/B Ratio (TTM) | 1.58 | N/A |
| P/FCF Ratio (TTM) | 13.59 | N/A |
| Price to 5YR AVG Earnings Ratio | 10.06 | N/A |
| Price to 5YR AVG FCF Ratio | 9.35 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.08% | N/A |
| ROE (TTM) | 11.04% | N/A |
| Net Profit Margin (TTM) | 1.47% | N/A |
| ROIC 5YR AVG | 13.55% | N/A |
Growth (82%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 57.22% | 495.38% | 287.07% |
| Revenue | -0.84% | 4.18% | 6.74% |
| Net Income | 55.55% | 471.45% | 274.60% |
| Cash Flow | 20.59% | 186.29% | 119.48% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.28 | N/A |
| Quick Ratio (TTM) | 0.52 | N/A |
| D/E Ratio (TTM) | 2.03 | N/A |
| Interest Coverage (TTM) | 2.21 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 2.07 | N/A |
| LTL to 5YR AVG FCF | 11.35 | N/A |
| Shares Outstanding Growth 5YR AVG | 2.01% | N/A |